Key result
Expression of lncRNAs ATP6V0E2-AS1, EPB41L4A-AS1, FGD5-AS1, and WWC2-AS2 was significantly increased in NFPA samples compared with adjacent non-tumoral samples (P=0.037, 0.007, 0.008, and 0.03).
Why the study?
Non-functioning pituitary adenoma carcinogenesis depends on several molecular players, and the role of long non-coding RNAs in tumorigenesis has only recently been recognized.
Observational
p-value: p=0.037, 0.007, 0.008, 0.03
Four lncRNAs (ATP6V0E2-AS1, EPB41L4A-AS1, FGD5-AS1, WWC2-AS2) are significantly upregulated in non-functioning pituitary adenomas compared to non-tumoral tissue.
LncRNA expression in NFPAs remains exploratory; leaves open mechanistic and clinical roles pending validation.
Non-functioning pituitary adenomas (NFPAs) are a group of pituitary tumors lacking manifestations linked to high hormone production, such as acromegaly and Cushing’s syndrome. NFPA carcinogenesis depends on several molecular players. Long non-coding RNAs (lncRNAs) are a class of molecular players whose role in tumorigenesis has just recently been recognized. In the current study, we appraised expressions of 5 lncRNAs, namely FGD5-AS1, ATP6V0E2-AS1, ARHGAP5-AS1, WWC2-AS2 and EPB41L4A-AS1 in NFPAs versus their corresponding non-tumoral samples. Expressions of ATP6V0E2-AS1, EPB41L4A-AS1, FGD5-AS1 and WWC2-AS2 were significantly increased in NFPA samples compared with adjacent non-tumoral samples (P values=0.037, 0.007, 0.008 and 0.03, respectively). However, expression of ARHGAP5-AS1 was not different between NFPA samples and controls (P value=0.62). EPB41L4A-AS1 and FGD5-AS1 could discriminate between NFPA samples and adjacent non-tumoral samples (P values=0.03 and 0.04, respectively). However, the AUC values were not appropriate. There was a significant positive association between age of NFPA patients and invasiveness of NFPA (χ2 =4.24, P value= 0.039). Moreover, there was a significant positive association between diseases duration and CSF leak (χ2 =11.4, p value=0.023). Finally, there was a significant positive association between tumor size and Knosp classification (χ2 =11.5, p value= 0.02) and invasiveness of NFPA (χ2 =6.12, p value= 0.04). The current study provides information about dysregulation of lncRNAs in NFPAs and warrants additional studies in this field.
No takes yet. Share an insight, caveat, or question.
Ghafouri‐Fard et al. (2023) conducted an observational in Non-functioning pituitary adenomas (NFPAs). Non-functioning pituitary adenomas vs. Adjacent non-tumoral samples was evaluated on Expression of lncRNAs (ATP6V0E2-AS1, EPB41L4A-AS1, FGD5-AS1, WWC2-AS2) (p=0.037, 0.007, 0.008, 0.03). Expression of lncRNAs ATP6V0E2-AS1, EPB41L4A-AS1, FGD5-AS1, and WWC2-AS2 was significantly increased in NFPA samples compared with adjacent non-tumoral samples (P=0.037, 0.007, 0.008, and 0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: